Ridgetech Announces 1-for-150 Reverse Stock Split
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Should l Buy RDGT?
Source: Newsfilter
- Reverse Stock Split Plan: Ridgetech announced a 1-for-150 reverse stock split effective April 7, 2026, reducing its outstanding shares from 134,835,960 to approximately 898,906, aimed at increasing share price to meet Nasdaq listing requirements.
- Trading Continuity: Following the reverse split, the ordinary shares will continue to trade on Nasdaq under the symbol "RDGT," with a new CUSIP number G2124G 203, ensuring liquidity and visibility for investors on trading platforms.
- Shareholder Rights Protection: The reverse split will uniformly affect all shareholders, with minor adjustments for fractional shares, but will not alter any shareholder's percentage interest in the company's ordinary shares, aiming to protect shareholder interests.
- Board Approval: The reverse split plan has been approved by the company's board of directors and shareholders, reflecting management's confidence in the company's future growth and laying the groundwork for subsequent capital operations and market performance.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy RDGT?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on RDGT
About RDGT
Ridgetech Inc, formerly China Jo-Jo Drugstores Inc, is a retailer and distributor of pharmaceutical and other healthcare products. The Company operates in four business segments. The Retail Drugstores segment sells prescription and over the counter (OTC) medicines, traditional Chinese medicine (TCM), dietary supplements, medical devices, and sundry items to retail customers. The Online Pharmacy segment sells OTC drugs, dietary supplements, medical devices and sundry items through its own and third-party platforms. The Wholesale Business segment includes supplying the Company's own retail drugstores and selling them to other drug vendors and hospitals. The Farming and Selling Herbs segment cultivates selected herbs for sales to other drug vendors.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Ridgetech Announces 1-for-150 Reverse Stock Split
- Reverse Stock Split Plan: Ridgetech announced a 1-for-150 reverse stock split effective April 7, 2026, reducing its outstanding shares from 134,835,960 to approximately 898,906, aimed at increasing share price to meet Nasdaq listing requirements.
- Trading Continuity: Following the reverse split, the ordinary shares will continue to trade on Nasdaq under the symbol "RDGT," with a new CUSIP number G2124G 203, ensuring liquidity and visibility for investors on trading platforms.
- Shareholder Rights Protection: The reverse split will uniformly affect all shareholders, with minor adjustments for fractional shares, but will not alter any shareholder's percentage interest in the company's ordinary shares, aiming to protect shareholder interests.
- Board Approval: The reverse split plan has been approved by the company's board of directors and shareholders, reflecting management's confidence in the company's future growth and laying the groundwork for subsequent capital operations and market performance.
See More
Ridgetech Announces 1-for-150 Reverse Stock Split
- Reverse Stock Split Plan: Ridgetech has announced a 1-for-150 reverse stock split effective April 7, which will reduce its outstanding shares from 134,835,960 to approximately 898,906, aiming to enhance share price and attract investor interest.
- Stock Price Impact: Prior to the split announcement, RDGT's stock closed at $0.0246 on Nasdaq, down 11.51%, indicating market concerns regarding the company's financial health, and the reverse split may be a strategy to improve its market image.
- Split Details: Under the plan, every 150 shares will convert into 1 new share with a par value increase from $0.001 to $0.15, which not only reduces the number of shares in circulation but may also enhance comparability of earnings per share.
- Market Reaction Expectations: While reverse splits are often seen as a sign of financial distress, if successfully executed, it could restore investor confidence and create conditions for future financing, helping the company reposition itself in a competitive market.
See More
Ridgetech Announces 1-for-150 Reverse Stock Split Plan
- Reverse Split Implementation: Ridgetech announced a 1-for-150 reverse stock split effective April 7, 2026, reducing its outstanding shares from 134.83 million to approximately 898,906, thereby increasing per-share value and improving shareholder structure.
- Trading Adjustment Timing: The reverse split will take effect at 5:00 PM Eastern Time, with trading on a split-adjusted basis commencing on the next trading day, ensuring market liquidity and investor confidence.
- New CUSIP Number: Following the reverse split, the new CUSIP number for the ordinary shares will be G2124G 203, facilitating investor identification and trading while enhancing transparency.
- Impact on Shareholder Equity: Each 150 shares will automatically convert into one share with a par value of $0.15, aimed at elevating the stock price to meet listing requirements, potentially attracting more institutional investors.
See More
Ridgetech Announces 1-for-150 Reverse Stock Split
- Reverse Stock Split Plan: Ridgetech announced a 1-for-150 reverse stock split effective April 7, 2026, reducing its outstanding shares from 134,835,960 to approximately 898,906, aimed at increasing share price to attract more investor interest.
- Trading Continuity: Post-split, Ridgetech's ordinary shares will continue trading on the Nasdaq Capital Market under the symbol 'RDGT', indicating the company's intention to maintain market liquidity and bolster investor confidence through this action.
- Shareholder Rights Protection: The reverse stock split will uniformly affect all shareholders, with adjustments for fractional shares, ensuring that shareholders' percentage interests in the company's ordinary shares remain unchanged, thereby safeguarding shareholder value.
- Corporate Governance Transparency: The reverse stock split plan has been approved by Ridgetech's board and shareholders, with a Fifth Amended and Restated Memorandum to be filed with the Cayman Islands Registrar, reflecting the company's commitment to governance transparency and compliance.
See More
Ridgetech Unveils Dual-Engine Growth Strategy for 2026
- Supply Chain Integration Strategy: Ridgetech plans to enhance its competitiveness in China's pharmaceutical and healthcare market by integrating its wholesale distribution network and B2B platform, which is expected to accelerate the transition from a traffic-driven to a value-driven business model.
- Digital Innovation Driving Growth: Subsidiary Allright will serve as the core digital engine, aiming to expand its customer base to 300,000 in 2026, achieve a 30% year-on-year increase in new B2B customers, and exceed a 30% online business penetration rate, further enhancing market influence.
- Synergistic Dual-Engine Effects: Ridgetech will integrate its offline wholesale platform Jiuxin Medicine with Allright to optimize procurement and sales processes, improving response speed and operational agility, thereby achieving higher turnover efficiency.
- Management Strategic Outlook: CEO Frank Zhao stated that the company is committed to achieving its 2026 and medium- to long-term strategic objectives through a clear strategic roadmap and an open collaborative framework, driving high-quality development and enhancing market position.
See More
Ridgetech Unveils Dual-Engine Growth Strategy for 2026
- Supply Chain Integration Strategy: Ridgetech plans to achieve dual breakthroughs in business model innovation and value creation in 2026 by integrating its wholesale distribution network and B2B platform, thereby strengthening its long-term growth foundation in China's pharmaceutical and healthcare supply chain.
- Core Business Enhancement: The company aims to further enhance the competitiveness of its wholesale business by deepening strategic cooperation with core suppliers and expanding distribution coverage of high-margin brands, which is expected to accelerate its transformation from a traffic-driven to a value-driven business model.
- Digital Innovation Driving Growth: Ridgetech's wholly-owned subsidiary Allright will serve as the core digital engine, targeting to expand its customer base to 300,000, achieve a 30% year-on-year increase in new B2B customers, and exceed a 30% online business penetration rate in 2026.
- Synergistic Dual-Engine Effects: Ridgetech plans to systematically introduce Jiuxin Medicine's supply chain products onto the Allright platform, optimizing procurement and sales processes to enhance operational agility, thereby establishing a virtuous cycle where
See More
Ridgetech Announces 1-for-150 Reverse Stock Split
- Reverse Stock Split Plan: Ridgetech announced a 1-for-150 reverse stock split effective April 7, 2026, reducing its outstanding shares from 134,835,960 to approximately 898,906, aimed at increasing share price to meet Nasdaq listing requirements.
- Trading Continuity: Following the reverse split, the ordinary shares will continue to trade on Nasdaq under the symbol "RDGT," with a new CUSIP number G2124G 203, ensuring liquidity and visibility for investors on trading platforms.
- Shareholder Rights Protection: The reverse split will uniformly affect all shareholders, with minor adjustments for fractional shares, but will not alter any shareholder's percentage interest in the company's ordinary shares, aiming to protect shareholder interests.
- Board Approval: The reverse split plan has been approved by the company's board of directors and shareholders, reflecting management's confidence in the company's future growth and laying the groundwork for subsequent capital operations and market performance.
See More
Ridgetech Announces 1-for-150 Reverse Stock Split
- Reverse Stock Split Plan: Ridgetech has announced a 1-for-150 reverse stock split effective April 7, which will reduce its outstanding shares from 134,835,960 to approximately 898,906, aiming to enhance share price and attract investor interest.
- Stock Price Impact: Prior to the split announcement, RDGT's stock closed at $0.0246 on Nasdaq, down 11.51%, indicating market concerns regarding the company's financial health, and the reverse split may be a strategy to improve its market image.
- Split Details: Under the plan, every 150 shares will convert into 1 new share with a par value increase from $0.001 to $0.15, which not only reduces the number of shares in circulation but may also enhance comparability of earnings per share.
- Market Reaction Expectations: While reverse splits are often seen as a sign of financial distress, if successfully executed, it could restore investor confidence and create conditions for future financing, helping the company reposition itself in a competitive market.
See More
Ridgetech Announces 1-for-150 Reverse Stock Split Plan
- Reverse Split Implementation: Ridgetech announced a 1-for-150 reverse stock split effective April 7, 2026, reducing its outstanding shares from 134.83 million to approximately 898,906, thereby increasing per-share value and improving shareholder structure.
- Trading Adjustment Timing: The reverse split will take effect at 5:00 PM Eastern Time, with trading on a split-adjusted basis commencing on the next trading day, ensuring market liquidity and investor confidence.
- New CUSIP Number: Following the reverse split, the new CUSIP number for the ordinary shares will be G2124G 203, facilitating investor identification and trading while enhancing transparency.
- Impact on Shareholder Equity: Each 150 shares will automatically convert into one share with a par value of $0.15, aimed at elevating the stock price to meet listing requirements, potentially attracting more institutional investors.
See More
Ridgetech Announces 1-for-150 Reverse Stock Split
- Reverse Stock Split Plan: Ridgetech announced a 1-for-150 reverse stock split effective April 7, 2026, reducing its outstanding shares from 134,835,960 to approximately 898,906, aimed at increasing share price to attract more investor interest.
- Trading Continuity: Post-split, Ridgetech's ordinary shares will continue trading on the Nasdaq Capital Market under the symbol 'RDGT', indicating the company's intention to maintain market liquidity and bolster investor confidence through this action.
- Shareholder Rights Protection: The reverse stock split will uniformly affect all shareholders, with adjustments for fractional shares, ensuring that shareholders' percentage interests in the company's ordinary shares remain unchanged, thereby safeguarding shareholder value.
- Corporate Governance Transparency: The reverse stock split plan has been approved by Ridgetech's board and shareholders, with a Fifth Amended and Restated Memorandum to be filed with the Cayman Islands Registrar, reflecting the company's commitment to governance transparency and compliance.
See More
Ridgetech Unveils Dual-Engine Growth Strategy for 2026
- Supply Chain Integration Strategy: Ridgetech plans to enhance its competitiveness in China's pharmaceutical and healthcare market by integrating its wholesale distribution network and B2B platform, which is expected to accelerate the transition from a traffic-driven to a value-driven business model.
- Digital Innovation Driving Growth: Subsidiary Allright will serve as the core digital engine, aiming to expand its customer base to 300,000 in 2026, achieve a 30% year-on-year increase in new B2B customers, and exceed a 30% online business penetration rate, further enhancing market influence.
- Synergistic Dual-Engine Effects: Ridgetech will integrate its offline wholesale platform Jiuxin Medicine with Allright to optimize procurement and sales processes, improving response speed and operational agility, thereby achieving higher turnover efficiency.
- Management Strategic Outlook: CEO Frank Zhao stated that the company is committed to achieving its 2026 and medium- to long-term strategic objectives through a clear strategic roadmap and an open collaborative framework, driving high-quality development and enhancing market position.
See More
Ridgetech Unveils Dual-Engine Growth Strategy for 2026
- Supply Chain Integration Strategy: Ridgetech plans to achieve dual breakthroughs in business model innovation and value creation in 2026 by integrating its wholesale distribution network and B2B platform, thereby strengthening its long-term growth foundation in China's pharmaceutical and healthcare supply chain.
- Core Business Enhancement: The company aims to further enhance the competitiveness of its wholesale business by deepening strategic cooperation with core suppliers and expanding distribution coverage of high-margin brands, which is expected to accelerate its transformation from a traffic-driven to a value-driven business model.
- Digital Innovation Driving Growth: Ridgetech's wholly-owned subsidiary Allright will serve as the core digital engine, targeting to expand its customer base to 300,000, achieve a 30% year-on-year increase in new B2B customers, and exceed a 30% online business penetration rate in 2026.
- Synergistic Dual-Engine Effects: Ridgetech plans to systematically introduce Jiuxin Medicine's supply chain products onto the Allright platform, optimizing procurement and sales processes to enhance operational agility, thereby establishing a virtuous cycle where
See More
